Intellectual Property UK

  • May 20, 2026

    Bose Loses Patent Appeal For Earbud Detection System

    Bose has failed to convince European officials to reconsider its patent for an earbud detection device, after an appellate board found that the invention relied on overly broad language that would make it difficult for a skilled person to reproduce.

  • May 20, 2026

    Glenmark Beats Boehringer's TM Over An Inhaler's Shape

    Glenmark has convinced European officials to nix a Boehringer trademark over the shape of an inhaler, after showing that its features were commonplace for the devices and lacked any special features that would catch people's attention on pharmacy shelves. 

  • May 20, 2026

    Stada Joins Effort To Void Takeda's ADHD Drug IP In UK

    Stada has asked a London court to annul Takeda's extended patent protections over ADHD drug Elvanse, echoing Aristo's claim that the U.K. supplementary protection certificate covering the drug is invalid.

  • May 20, 2026

    Armani Loses Case For 'Exotic Musk' TM In EU

    European officials have refused Giorgio Armani's trademark application for "Exotic Musk," ruling that the phrase is too descriptive because perfume brands commonly use it to describe warm and musky scents. 

  • May 20, 2026

    Next Blocks 'Nextweek' TM Bid From Sunglasses Biz

    British clothing retailer Next has persuaded European Union officials to block a "Nextweek" trademark application from a Chinese sunglasses company, proving that shoppers could easily mistake one logo for the other.

  • May 19, 2026

    Vape Co. Disputes Rival's 'Original' Ownership Of TM

    An electronic cigarette brand has pushed back against claims it copied a rival's "Crystal Vapours" trademark, arguing that the rival wasn't the "original user" of the sign as it didn't even own the shops it was citing as evidence.

  • May 19, 2026

    IOC Shreds Ex-Pro Snowboarder's 'Olympic Angels' EU TM

    The governing body of the Olympics has stopped a former professional snowboarder from getting an "Olympic Angels" trademark in the European Union, proving that the mark unfairly free-rides on the competition's reputation.

  • May 19, 2026

    Nxera Sues Rival Biotech Over Drug Research Patent

    Biopharma business Nxera has accused a rival of infringing its patents covering an engineered version of a protein used extensively in drug discovery research, arguing that the specific variants the biotech used were far too similar to the patented technology.  

  • May 19, 2026

    InterDigital Loses Appeal For Video Coding Patent

    European appellate officials have rejected InterDigital's bid to patent a method of decoding videos, ruling that earlier technology had already disclosed the idea of "upsampling" video layers to allow streams to play a higher-quality display. 

  • May 19, 2026

    Property Investor Sues Ares For Using 'Marq' IP

    A London-based property investor has accused U.S. investment giant Ares of infringing its trademark by reproducing identical logos in an effort to capitalize on the investor's success and mislead consumers.

  • May 18, 2026

    Former USPTO Directors Diverge On Patent Injunctions

    The debate over the role of injunctions in patent cases remains active in the U.S., and European leaders shouldn't think that there is a "consensus" in the country, said former U.S. Patent and Trademark Office Director Kathi Vidal.

  • May 18, 2026

    Nokia Can't Force Acer, Asus To Arbitrate Over Their SEPs

    An appeals court told Nokia on Monday that it cannot compel Acer and Asus to arbitrate over cross-licenses for their own patents in upcoming arbitration over suitable licenses for the Finnish company's essential video-coding technology.

  • May 18, 2026

    Shiseido Can't Bag 'Collection Créateurs de Merveilles' TM

    European officials have refused Shiseido's application for the trademark "Collection Créateurs de Merveilles" covering cosmetic products, finding that shoppers would be likely to see it as a promotional statement rather than a distinct brand.

  • May 18, 2026

    Bayer Nixes Generic's Anticoagulant Patent

    Bayer has persuaded European appellate officials to ditch a Slovenian drugmaker's patent over a compound that helps prevent blood clots, after showing that it lacked key information scientists needed to make the drug. 

  • May 18, 2026

    Fashion Brand Alaïa Blocks Chinese Rival's 'Ailiai' TM

    French fashion house Alaïa has convinced European officials to partially nix a Chinese shoemaker's mark, as shoppers looking to buy high-end handbags and clothes from the luxury brand might be tricked into buying the rival's products. 

  • May 18, 2026

    Ebay Blocks 'BotBay' TM Application From Croatian Biz

    EBay has halted a Croatian company's "BotBay" trademark application, convincing European Union officials that consumers could see the logo as an extended brand of its popular online marketplace.

  • May 18, 2026

    Monster Fails To Get 'Pink Poison' Hard Seltzer TM

    The brewing branch of energy drinks giant Monster has failed to secure a European Union trademark for its "Pink Poison" hard seltzer after a French winery proved that there is a risk of confusion with its earlier "Poison Rose" brand.

  • May 15, 2026

    Guy Laroche Wins EUIPO Fight Over Lookalike 'G' Logo

    Guy Laroche has convinced European officials to block an online retailer from registering a stylized "G" logo as a trademark, with the French fashion brand proving that consumers would likely confuse them at face value.

  • May 15, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen singer Rita Ora be sued by her management company, the billionaire Gertner brothers file a part 8 claim and Stephenson Harwood lodge a debt claim against a member of the Bulgari jewelry dynasty. Here, Law360 looks at these and other new claims in the U.K.

  • May 15, 2026

    EU Asks How To Balance IP Rights With AI Boom

    The European Commission is asking experts how best to strengthen copyright enforcement and licensing laws in response to the rapid rise of artificial intelligence, while "making it easier" for generative AI companies to access their works.

  • May 15, 2026

    Merck Blocks Rival's Access To Secret Files In Trademark Row

    German drugmaker Merck KGaA successfully blocked pharmaceutical rival Merck Sharp & Dohme LLC from accessing a cache of confidential files which featured in a trademark dispute between the pair, as a London court ruled Friday that MSD is contractually bound not to use the documents.

  • May 15, 2026

    VW, DHL Counterfeit Car Key Battle Heads To Top Dutch Court

    A Dutch judge is set to refer a dispute between VW and DHL over a shipment of allegedly counterfeit car keys to the nation's top court, aiming to clarify whether the Dutch or German courts have jurisdiction to hear the case.

  • May 15, 2026

    Invisalign Maker Loses Bid For Early Injunction At UPC

    An orthodontics company has failed to secure an injunction barring a rival from selling clear aligners after the Unified Patent Court found that it relied too heavily on marketing materials that failed to show any identical features. 

  • May 15, 2026

    Brandsmiths Client Hit With Costs Penalty Over SRA Threat

    A London court has ordered a discount retailer to pay indemnity costs, finding the company's solicitors Brandsmiths misused criminal contempt proceedings and threatened to report their opposition lawyers to the profession's regulator in an attempt to gain leverage in a trademark dispute.

  • May 15, 2026

    Klarna Wins Battle For 'K.' TM For Non-Banking Services

    A European court has rejected Klarna's bid to obtain exclusive rights over a "K." trademark in the banking world, but allowed the fintech firm to keep its logo registered over a range of non-financial services despite a Spanish rival's attacks. 

Expert Analysis

  • Trade Agreements With EU Will Still Be Elusive Post-Brexit

    Author Photo

    Although a post-Brexit transitional arrangement largely preserves the status quo between the U.K. and the EU through the end of the year, intense trade negotiations for key industries are still to come, with the possibility of a no-deal exit in 2021, say attorneys at Baker Botts.

  • Surefire Marketing Methods To Build Your Legal Practice

    Author Photo

    Attorneys who take the time and the risk to showcase their talents through speaking, writing and teaching will find that opportunities will begin building upon themselves, says Daniel Karon of Karon LLC.

  • Some Clarity On Inventor-Employee Compensation In The UK

    Author Photo

    The recent U.K. Supreme Court decision in Shanks v. Unilver swept away a perception that some employers are simply too big to pay inventor compensation under the U.K.’s statutory compensation provisions, and may offer some hope to prospective employees, say attorneys at Haseltine Lake.

  • The Rise Of Patent Wars In Europe's Gene Therapy Space

    Author Photo

    Drug companies can prepare for increasing competition and a rise in contentious patent proceedings in Europe’s gene therapy industry by aligning patents, orphan designations and data exclusivity where possible, say Jane Hollywood and Frances Denney of CMS Legal.

  • Self-Driving Vehicles' Neural Networks Present IP Conundrum

    Author Photo

    While autonomous vehicles' use of artificial intelligence through neural networks is highly innovative, the position of these networks within intellectual property has yet to be cemented, and a debate is ongoing as to whether they are best protected by patent, database rights or copyright, say Rajvinder Jagdev and Lin Liu of Powell Gilbert.

  • Failure To Launch: The Patent Thicket Delay Of US Biosimilars

    Author Photo

    Almost 10 years after enactment of the Biologics Price Competition and Innovation Act, AbbVie’s assertion of 18 patents against three Humira biosimilars shows that patent thickets remain an obstacle to launching follow-on biologics and help explain why U.S. launches lag behind those in Europe, say attorneys at Axinn.

  • Huawei Case Might Mean UK Forum Sets Global FRAND Rates

    Author Photo

    The U.K. Supreme Court’s eventual opinion in Unwired Planet v. Huawei will decide whether English courts are a proper forum for determining global fair license terms for standard-essential patents, and there are several reasons to question the English courts' creation of this approach, says Thomas Cotter of the University of Minnesota Law School.

  • Must Inventors Be Humans? An Active Debate Over AI Patents

    Author Photo

    With the first international patents naming artificially intelligent algorithms as inventors filed this summer, and with the U.S. Patent and Trademark Office’s query into whether inventorship laws and regulations need revising, the debate over AI is testing the boundaries of patent laws in the U.S. and elsewhere, says Christian Mammen of Womble Bond.

  • Henry Schein Case Illuminates Maze Of Arbitrability Questions

    Author Photo

    While the U.S. Supreme Court’s Henry Schein decision strengthens the enforceability of arbitration provisions, the Fifth Circuit’s ruling on remand concerning arbitrability authority, exemplifies a need for careful drafting of arbitration clauses, say Andrew Behrman and Brandt Thomas Roessler at Baker Botts.

  • Using Global Dossier To Simplify USPTO Disclosure Duty

    Author Photo

    The U.S. Patent and Trademark Office can make compliance with its duty of disclosure less burdensome by allowing applicants to submit a list of patent families that are believed to have material information and defining electronically available records broadly to include the Global Dossier, whose use the USPTO recently encouraged, says Brian Dorini of InterDigital CE Holdings.

  • The Unique Challenges Of Owning International Cannabis IP

    Author Photo

    Due to the cost of prosecuting patents and the uncertainty in obtaining and enforcing cannabis patents in foreign jurisdictions, building a global cannabis patent portfolio presents complex strategic questions, says Jayashree Mitra of Zuber Lawler.

  • IP Protection Still Elusive For Data Compilations In US And EU

    Author Photo

    As businesses continue to increase investment into artificial intelligence systems, questions arise as to whether they can own or legally protect data compiled by those systems. Currently, in the U.S. and EU, obtaining copyright protection for databases is difficult and trade secret protection requires policies and procedures to establish rights, say attorneys at Mayer Brown.

  • Perspectives

    Artisanal Miners' Roadblocks To Justice: Is A Path Clearing?

    Author Photo

    Efforts to give small-scale gold miners, who face displacement, pollution and violence at sites around the world, access to fair and functioning justice systems have met with apathy from politicians and fierce resistance from powerful business lobbies, but there are signs that this may be changing, says Mark Pieth, president of the Basel Institute on Governance.

  • How PTAB Is Applying New Patent Eligibility Guidance

    Author Photo

    Since the U.S. Patent and Trademark Office released its revised patent eligibility guidance in January, the Patent Trial and Appeal Board has been reversing Section 101 rejections at a higher rate, say Nick Anderson and Braden Katterheinrich of Faegre Baker Daniels.

  • Keys To Successful AI Patents In The US And Europe

    Author Photo

    Unsurprisingly, the World Intellectual Property Organization recently reported that patent filings for artificial intelligence inventions are increasing rapidly. Stakeholders should be mindful of maintaining quality during this filing surge, says Drew Schulte of Haley Guiliano LLP.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.